2024 expectations for Wegovy, Ozempic, Zepbound
George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024 will bring more change to the evolving market. The drugs skyrocketed …
Pfizer Inc
Jim Cramer says some investors are headed for a ‘nasty hangover’
CNBC’s Jim Cramer on Monday suggested that investors are not buying with a clear head and are choosing too many poorly-performing stocks. “I saw a hammered market, a market where …
Why Pfizer’s stumble in the obesity market is a boon for Eli Lilly
Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain …
Pfizer to discontinue twice-daily version of weight loss pill
Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost weight but had trouble tolerating the …
Tim Cook, Elon Musk, Steve Schwarzman spotted
Apple CEO Tim Cook attends the “Senior Chinese Leader Event” held by the National Committee on US-China Relations and the US-China Business Council on the sidelines of the Asia-Pacific Economic …
Pfizer enters weight loss drug market with Novo Nordisk, Eli Lilly
CFOTO | Future Publishing | Getty Images As its Covid gains evaporate, Pfizer wants a chunk of the budding weight loss drug market. Analysts say upcoming data on Pfizer’s experimental …
AstraZeneca adds to obesity drug race, but Eli Lilly remains in lead
Eli Lilly (LLY) remains our favorite way to play the weight-loss drug market, despite a new entry this week from AstraZeneca (AZN). On Thursday, AstraZeneca said it paid $185 million …
Eli Lilly diabetes drug Mounjaro supply improves in U.S.
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, March 29, 2023. …
Moderna (MRNA) Q3 earnings report 2023
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Thursday posted a steep loss for the third quarter as the drugmaker recorded a large write-down due to unused Covid vaccines, …
Pfizer (PFE) Q3 earnings report 2023
CFOTO | Future Publishing | Getty Images Pfizer on Tuesday reported a narrower than expected loss for the third quarter as the drugmaker recorded charges largely related to struggles for …